All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other alimentary tract and metabolism products

Pombiliti

(cipaglucosidase alfa)

Uses, side effects, dosage information & price range

Amicus Therapeutics Europe Limited

About this medicine

Pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset Pompe disease (acid ?-glucosidase [GAA] deficiency).

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

UcedaneComposition: carglumic acidEurocept International BV
Price on RequestView Details →
SephienceComposition: sepiapterinPTC Therapeutics International Limited
Price on RequestView Details →
CerdelgaComposition: eliglustatSanofi B.V.
Price on RequestView Details →
ProcysbiComposition: mercaptamineChiesi Farmaceutici S.p.A
Price on RequestView Details →
Sapropterin DipharmaComposition: sapropterinDipharma Arzneimittel GmbH
Price on RequestView Details →

Key Information

Salt / Composition

cipaglucosidase alfa

Category

Other alimentary tract and metabolism products

Manufacturer

Amicus Therapeutics Europe Limited

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.